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Solution Structure of the Proapoptotic
Molecule BID: A Structural Basis for
Apoptotic Agonists and Antagonists
(BAX, BAK, and BOK) versus antiapoptotic (BCL2, BCL-
XL, BCL-W, MCL1, and A1) members determines in part
how cells respond to proximal death and survival signals
(Oltvai et al., 1993). Mutagenesis of BCL2 indicated that
intact BH1 and BH2 domains were required to interact
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with BAX and to repress cell death (Yin et al., 1994).²Howard Hughes Medical Institute
Moreover, deletions within BAK (Chittenden et al., 1995)Washington University School of Medicine
and an extensive mutagenesis of BAX (Wang et al., 1998)St. Louis, Missouri 63110
indicated that the amphipathic BH3 domain of proapo-
ptotic molecules was critical for dimerization and death.
A divergent subset of the BCL2 family possesses sub-Summary
stantial sequence homology only within the conserved
BH3 domain. These ªBH3 domain onlyº members in-Members of the BCL2 family of proteins are key regula-
clude the mammalian BID, BAD, BIK, BIM, BLK, andtors of programmed cell death, acting either as apo-
HRK, all of which are proapoptotic. This lends credenceptotic agonists or antagonists. Here we describe the
to the thesis that BH3 represents a minimal death do-solution structure of BID, presenting the structure of
main (Boyd et al., 1995; Yang et al., 1995; Wang et al.,a proapoptotic BCL2 family member. An analysis of
1996; Inohara et al., 1997; Hegde et al., 1998; O'Connorsequence/structure of BCL2 family members allows
et al., 1998). The identification of a ªBH3 domain onlyºus to define a structural superfamily, which has impli-
member in C. elegans, EGL-1, argues that this class ofcations for general mechanisms for regulating pro-
death effectors is a conserved component of a centralapoptotic activity. It appears two criteria must be met
death pathway (Conradt and Horvitz, 1998). Like otherfor proapoptotic function within the BCL2 family: tar-
members of this class of molecules, BID shows no rec-geting of molecules to intracellular membranes, and
ognizable sequence homology to BH1, 2, or 4 domainsexposure of the BH3 death domain. BID's activity is
and requires the BH3 domain for its heterodimerizationregulated by a Caspase 8±mediated cleavage event,
with BAX, BCL2, or BCL-XL (Wang et al., 1996). Muta-exposing the BH3 domain and significantly changing
tional analysis indicated that an intact BH3 domain, per-the surface charge and hydrophobicity, resulting in a
haps one that retained interaction with BAX, was also
change of cellular localization.
required for the apoptotic activity of BID.
Evolving evidence suggests that the proapoptotic
Introduction BCL2 members may exist in inactive and active forms.
BAX, despite possessing a hydrophobic C terminus,
Programmed cell death is a highly conserved biological exists in the soluble fraction of cells as well as in mito-
process critical for all multicellular organisms (Ellis et chondrial membranes. Death stimuli ranging from stau-
al., 1991; Raff, 1992). This process allows for the removal rosporine to the withdrawal of survival factors result in
of noninstructed, misinstructed, as well as damaged the translocation of monomeric BAX from the cytosol
cells, playing a critical role in embryonic development, to mitochondria, where it is apparently a homodimeric
the maintenance of tissue homeostasis, and immuno- integral membrane protein (Wolter et al., 1997; Gross et
logical defense (Thompson, 1995; Strasser et al., 1997). al., 1998). The ªBH3 domain onlyº molecules are attrac-
Dysregulated programmed cell death can contribute to tive candidates to connect proximal signal transduction
cancer, autoimmunity, immunodeficiency, infertility, and events with the distal death effector mechanism by their
neurodegenerative disorders (Chao and Korsmeyer, 1998). posttranslational modification. For example, BAD is in-
Developmental or environmental cues deliver complex activated by phosphorylation in response to IL-3 survival
signals that promote cell death or survival. Dissection factor signaling, having a dual impact on BAD's location
of the cell death pathway has led to the identification of and its binding partners. Phosphorylated BAD is se-
a large number of both pro- and antiapoptotic molecules questered in the cytosol bound to 14-3-3, whereas only
(Adams and Cory, 1998). the active, nonphosphorylated BAD is capable of het-
The BCL2 family of proteins constitutes a critical deci- erodimerization with BCL-XL at membrane sites, thereby
sional checkpoint within the common portion of the preventing cell death (Zha et al., 1996). Recently, BID has
apoptotic pathway, upstream to the irreversible damage been reported to be activated by proteolytic cleavage by
to cellular constituents. The BCL2 family is comprised of an activated Caspase 8 in response to treatment with
both proapoptotic and antiapoptotic molecules (Adams TNFa or anti-FAS. The ªinactiveº p22 cytosolic BID is
and Cory, 1998; Chao and Korsmeyer, 1998). Full mem- cleaved at a caspase recognition site to produce a major
bers of the BCL2 family share homology in three or four p15 truncated fragment, referred to as tBID, that translo-
conserved domains entitled BH1±4. The ratio of pro- cates to mitochondria (Li et al., 1998; Luo et al., 1998;
Gross et al., 1999). The p15 tBID is capable of targeting
mitochondria, where it becomes an integral membrane³ To whom correspondence should be addressed (e-mail: cowburn@
protein.rockvax.rockefeller.edu).
Thus it remains critical to determine the three-dimen-§ Present address: Dana-Farber Cancer Institute, Harvard Medical
School, 1 Jimmy Fund Way, Boston, Massachusetts 02115. sional structure of a proapoptotic BCL2 family member
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Figure 1. BID Assignment and Secondary
Structure Summary
The secondary 13Ca chemical shift (DCa)
(Wishart et al., 1992), 3JHN-Ha (WuÈ thrich, 1986),
and dNN(i, i 1 1) NOE correlations (normalized
to a maximum intensity of 104) give strong
signals characteristic of helical structure in
the indicated regions. The hydrogen-deute-
rium exchange rates (HX) for backbone am-
ides are strongly protected in the helical ele-
ments. The rmsd values are the pairwise
values of 20 structures. S2 is the squared or-
der parameter for the 15N±1H amide of each
residue and is a direct measure of conforma-
tional flexibility on the nanosecond-picosec-
ond timescale; S2 5 1 in the absence of NH
bond reorientations, while S2 5 0 corre-
sponds to a completely unrestricted motion
of the bond.
to provide insight into how this subset of molecules all of the NMR experiments for assignment and structure
calculations were performed at 458C with increased ef-mediates cell death rather than survival. Multiple models
have been postulated to account for their prodeath ac- fective resolution. Backbone and side-chain assignment
was carried out using both the CBCA (Grzesiek andtivity. The characteristics of ªBH3 domain onlyº mole-
cules suggest they may serve as death ligands, sensors Bax, 1993) and NOE (WuÈ thrich, 1986) based assignment
strategies. Some residues at the unstructured N termi-that receive death signals in the cytosol and translocate
to membranes where they bind to either active or inac- nus (residues M1±S2) and in a large flexible loop (resi-
dues R31±E33, E52±Q56, and N68±G70) were not as-tive BCL2 members, serving as receptors (Wang et al.,
1996). An alternative theory of displacement holds that signed. Also, the correlations for several residues found
in loops were obtained primarily from the CBCA-basedthese proapoptotic molecules might displace Apaf1
from the BCL-XL pocket to activate a caspase cascade assignment approach, as line broadening from chemical
exchange made assignment of individual amide NOEs(Chinnaiyan et al., 1997). p15 tBID's role as an integral
membrane protein raises the possibility that it might difficult. Three sets of triple-resonance experiments (de-
scribed in Experimental Procedures) were used to definealso play a role as a pore former (Antonsson et al.,
1997; Schlesinger et al., 1997). Moreover, while the ªBH3 the backbone assignments. Additionally, extensive sets
of experiments were performed to analyze BID dynamicsdomain onlyº molecules have a short sequence homol-
ogy in the BH3 motif, it is essential to delineate the other and hydrodynamics.
The structure of the BID protein was defined based onparts of the molecular structures. Here we report the
solution structure of BID using NMR spectroscopy, pro- z1700 NMR-derived distance constraints. This included
1350 structurally relevant NOE-based constraints, 275viding the structure of a proapoptotic BCL2 family mem-
ber and offering insight into the structural basis of the dihedral angle constraints measured from J-coupling
constants and local bond geometry (Guntert et al., 1991),proapoptotic function of the BCL2 family death agonists.
Based on sequence/structure similarity or dissimilarity and constraints from 56 hydrogen bonds implied by
hydrogen-deuterium exchange experiments and localto BID, the mechanisms of other proapoptotic family
members are proposed, illustrating a fold class including secondary structure. This corresponds to an average
density of z15 constraints per residue in all regions ofboth p22 BID and the previously determined BCL-XL
structure (Muchmore et al., 1996; Sattler et al., 1997). secondary structure.
The structural changes caused by removing the N ter-
minus to produce p15 tBID suggest a mechanism for Structure Description of BID
proapoptotic activity of these family members. The three-dimensional structure of BID consists of eight
a helices arranged in three layers (Figure 2). Two central
hydrophobic helices (aF and aG) are surrounded by am-Results
phipathic helices on either side. There is a large disor-
dered loop between helices B and C; analysis of back-Structure Determination of BID
The structure of the full 22 kDa BID protein (residues bone dynamics (S2 values in Figure 1) gives a direct
measure of flexibility and confirms the conformational1±195) was determined using heteronuclear NMR spec-
troscopy. Initial 1H-15N HSQC maps showed a high de- mobility of the region. The C-terminal helix (aH) has well-
defined local structure, but no long-range NOEs aregree of spectral overlap at low temperatures. Since the
BID protein was found to be exceptionally thermostable, observed, so the helix is poorly defined relative to the
Structure of the Proapoptotic Death Domain BID
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Figure 2. The Three-Dimensional Structure of BID
(a) View of the backbone (N, Ca, C9) of 20 superimposed NMR-derived structures of BID. Helical elements are colored in red and loops in
white; the flexible amino terminus and the BC loop are not shown.
(b) A ribbon diagram of BID; helical segments are labeled. The figure was generated using SETOR (Evans, 1993).
(c) The average orientation of individual helices as calculated using anisotropic relaxation analyses. The x axis shows the angle u: the orientation
axis of each helix, calculated from the 20 NMR-derived structures, relative to the unique principal axis of the overall rotational diffusion tensor.
On the y axis is the value (2R29/R192 1)21, derived from relaxation measurements. The white line is the theoretical relationship between these
two parameters for a D‖/D⊥ ratio of 1.18. The individual values for helices aA, aB, aD, aE, aF, and aG are shown in yellow, helix aH in green,
and helix aC in red.
rest of the structure. However, its position in Figures of structural similarity was unexpected based on se-
quence comparisons. Compared with BCL-XL, BID has2a and 2b is fully supported by calculations of helix
orientation by analysis of relaxation data. Because BID is an additional helix (aB) before the disordered loop. This
helix is well defined and packs against aA and the FGhydrodynamically anisotropic, the longitudinal (R1) and
transverse (R2) relaxation rates provide structural orien- loop. A comparison with the BCL-XL structure reveals a
single helical turn in the analogous position (residuestation information (Broadhurst et al., 1995; Tjandra et
al., 1997) (described in Experimental Procedures). The W24±V30 in BCL-XL). Several other members of the BCL2
family also have a predicted possible helix in this posi-results of this analysis (Figure 2c) suggest that helix aC
is nearly parallel to the unique principal axis of the overall tion, so perhaps a short aB helix is a general characteris-
tic for this structural class of the BCL2 family. Rmsdsrotational diffusion tensor, while all the other helical seg-
ments are nearly perpendicular to this. This type of mea- between BID and BCL-XL (PDB code 1maz) (4.90 AÊ over
69 residues and seven helices) and BID and diphtheriasurement acts as an independent confirmation of the
NMR structures calculated using the traditional NOE- toxin (PDB code 1sgk) (4.13 AÊ over 38 residues and four
helices) are consistent with distantly related proteinsbased strategies. The global rms deviations for the first
seven helices (aA±aG) are 0.7 AÊ for backbone atoms belonging to the same structural class. Exposure of sur-
face components are, however, quite different (see Dis-(see Figure 1; further structure statistics are given in
Experimental Procedures). A bundle of the 20 lowest cussion).
target function NMR conformers and a ribbon diagram
depicting the elements of secondary structure are Structure Predictions for the BCL2 Superfamily
shown in Figures 2a and 2b, respectively. Having solved the BID structure, we asked what general
conclusions could be drawn for sequence/structure re-
lationships within the BCL2 family. We performed pri-Structural Comparison
Visual inspection clearly places the BID structure in the mary sequence alignments for family members belong-
ing to the different BCL2 subfamilies. Because primarySCOP classification fold class of toxins' membrane
translocation domains (Murzin et al., 1995). Despite the sequence analysis had failed to predict any structural
similarity between BID and BCL-XL outside of the BH3very low sequence homology between the two mole-
cules, the overall tertiary fold derived for BID is similar motif (Wang et al., 1996; Adams and Cory, 1998), we
also performed predictions of secondary structure forto that observed for the BCL-XL structure (Muchmore et
al., 1996; Sattler et al., 1997). This has independently family members. Patterns of secondary structure are
often more sensitive for structure prediction than pri-been observed by Chou et al. (1999 [this issue of Cell]),
who also solved the solution structure of BID. This level mary sequence comparison alone. For the sequence
Cell
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Figure 3. Sequence Alignment of BID with Other BCL2 Family Members and Secondary Structure Predictions for a Representative Set of
BCL2 Family Members
(a) Boxed regions represent the consensus helical elements, and BH regions are indicated. The principal consensus elements are based on
the BID structure; some helices, especially the short aB in BCL-XL, only approximately concur with observed φ, c angles. Residues in blue
are the helical elements in BID, while residues in red are the helical elements in BCL-XL. The green residues illustrate the conserved hydrophobic
repeat characteristic for amphipathic helices, implying a conservation of topology for this structural subclass of the BCL2 family. Note that
the 3-4 hydrophobic repeat is not present in helix aF because this is the central core helix and is not amphipathic. Additional sequence
alignments of other family members are available elsewhere (Chittenden et al., 1995; Muchmore et al., 1996).
(b) The proteins in this figure were chosen as a representative set of BCL2 family members. Helix aB is unusually long in BID compared with
other family members. The length of the BC loop is indicated by the boxed value. The red carat symbol in BCL-XS denotes the site of a 63-
amino-acid deletion compared with BCL-XL. Boundaries of secondary structure elements are often difficult to define. It is expected that there
is variability in these boundaries for the different family members; the helical representations in the figure are not meant to precisely define
these boundaries but rather to show similarities or differences across the family. The sequence numbers shown for secondary structure
boundaries in the group II family should also be considered approximate.
alignment of the BCL2 family, we used the program for secondary structure predictions for the various family
members, and where possible, the consensus from theCLUSTALW (Thompson et al., 1994) and aligned by hand
where CLUSTALW failed. Low levels of sequence simi- multiple approaches was used.
Based on sequence and secondary structure align-larity in this family made completely automated align-
ments impractical. The aligned sequences were used ments, members of the BCL2 family can be grouped into
Structure of the Proapoptotic Death Domain BID
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Figure 4. Comparison of BID and BCL-XL
BH123 Acceptor Region
(a) The BID and (b) BCL-XL±BAK complex
(PDB code 1lxl [Sattler et al., 1997]) structures
were colored according to surface hydropho-
bicity (red for hydrophobic, white for hydro-
philic) using GRASP (Nicholls et al., 1991).
The backbone worms for both BID and the
BCL-XL±BAK BH3 peptide complex are col-
ored yellow.
two main structural categories. Group I family members appears to be critical to the function of the antiapoptotic
molecules (Yin et al., 1994; Chittenden et al., 1995). Ifhave a sequence pattern consistent with the conserva-
dimerization with BCL2 family members through thistion of the BID/BCL-XL topology. The members of group
cleft is an important characteristic for death antagonism,I, including the proapoptotic molecules BID, BAX, and
it is clear why BID cannot function in an antiapoptoticBAK, will have their BH3 domain buried, and therefore
manner.must rely on some mechanism of conformational change
It is the hydrophobic surface of the amphipathic BH3to induce their proapoptotic activity. When one consid-
helices that mediates BCL2 dimerization events (Sattlerers the timescale on which apoptosis occursÐapoptotic
et al., 1997; Zha et al., 1997). In the BID structure, thiscell death generally takes less than 60 min (Thornberry
hydrophobic face of the BH3 helix (the aC residues indi-and Lazebnik, 1998)Ða posttranslational modification
cated in Figure 3a) is mostly buried and less availablethat serves as the ªon switchº appears to be the most
for avid interaction with BCL2 or other binding partners.realistic mechanism for structural and/or conformational
Presented as the whole 22 kDa protein, BID is predomi-activation. The group II BCL2 family members are either
nantly inactive. Upon cleavage by Caspase 8, BID be-truncated group I molecules (tBID, tBCL2, tBCL-XL, BCL-
comes an active p15 death-inducing product. In directXS) or family members that have an unrelated tertiary
binding experiments between BID/tBID and BCL-XL, itstructure (e.g., BAD); this class of family members
was demonstrated that in the absence of detergentsseems likely to have their BH3 domains surface exposed
tBID binds BCL-XL avidly, while a BID±BCL-XL complexand consequently, in contrast with BID, would be consti-
could not be detected (Li et al., 1998). Caspase 8 cleavestutively active.
cytosolic BID predominantly at D59 to yield a 15 kDa
proapoptotic fragment. D59 resides in the unstructuredDiscussion
loop (D59 S2 5 0.15) and would be predicted to be
completely available to proteolytic cleavage. The 15 kDaImplications of the BID Structure and Caspase
proapoptotic fragment loses helices aA and aB and a8 Cleavage
portion of the unstructured loop. Loss of these elements
BID does not form homodimers, nor does it serve as an
is predicted to induce a change of structure. A surface
acceptor for the BH3 motifs from other BCL2 family
of aA (residues aA1 [I16], aA5 [L20], and aA9 [F24])
members (Wang et al., 1996), because it lacks the groove forms a series of hydrophobic interactions with the BH3
formed by the BH motifs (called BH1, 2, 3) that is the helix (aC), while the aB helix packs against aA and the
ªacceptorº pocket of the BH3 binding event. Not only FG loop. When the aA helix is removed by Caspase 8
does BID lack the strong primary sequence homology cleavage, a large hydrophobic surface of the BH3 helix
to BH1 and BH2 motifs found in the full members of the (aC) is exposed. Interestingly, mutations of a hydropho-
family (Figure 3a), but the tertiary structure of the region bic surface in the first helix of BCL2 will convert BCL2
is quite different than that of BCL-XL, sufficient to pre- from an antiapoptotic to a proapoptotic molecule (Lee
clude the binding of a BH3 donor segment. Specifically, et al., 1996). We illustrate the structural effect of the
compared with the BCL-XL structure, and by analogy to Caspase 8 cleavage event by removing the first 59 resi-
BCL2 and BAX molecules, BID has a well-formed helix dues from the BID structure to generate a model of
at position aD that runs nearly antiparallel with aE; the tBID (Figure 5a versus Figure 5b). While the displayed
open groove seen in BCL-XL in this region is not present structures may not represent the conformation of tBID
(see Figure 4). Furthermore, BID has a deletion in the in vivo, as tBID rapidly becomes an integral membrane
EF loop (the BH1 region) (Figure 3a). While BCL-XL protein (Gross et al., 1999), the model presented for tBID
exposes a deep cleft of marked hydrophobicity, BID has in Figure 5b does suggest explanations for the changes
no such character in this region. The ability to form in tBID activity and cellular localization.
It is worth noting that this type of conversion to anhomodimers or heterodimers through the BH1, 2, 3 cleft
Cell
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Figure 5. Predicted Structural Effects of the
Caspase 8 Cleavage of BID
A ribbon diagram of (a) the full-length p22 BID
versus (b) the p15 tBID model (flexible loop
BC and amino terminus not shown). An analy-
sis of the exposed hydrophobic surface for
(c) BID and (d) the tBID model presented in
the same orientation as in (a) and (b). Hy-
drophobic surfaces were generated using
GRASP (Nicholls et al., 1991); here the gray
and yellow indicate hydrophobic and hydro-
philic surfaces, respectively.
active proapoptotic molecule is not without precedent charge of the two molecules; GRASP representations
of the p22 and p15 molecules are shown in Figures 6ain the BCL2 family. For both BCL2 and BCL-XL, caspase-
mediated cleavage of the flexible loop is sufficient for and 6b. Indeed, it seems likely that the large negative
charge associated with p22 BID might be sufficient toconversion from antiapoptotic to proapoptotic activity
(Cheng et al., 1997; Clem et al., 1998). Another example prevent a close association with the mitochondrial outer
membrane, which is among the most strongly negativelycan be seen in comparing the antiapoptotic BCL-XL with
the proapoptotic BCL-XS. BCL-XS is an alternatively charged biological membranes (Darnell et al., 1990). The
inactive p22 product is primarily (z90%) in the cytosol,spliced form of BCL-XL that lacks helices aE±aG (see
Figure 3b). The BCL-XS therefore lacks a hydrophobic while the p15 product is almost entirely associated with
mitochondria and capable of targeting mitochondria andsurface for the BH3 helix to pack against, allowing it
unfettered access for interaction. There is also evidence becoming integrated in the membrane (Gross et al.,
1999). While the death inducing activities associatedthat BAX can be cleaved in vivo, possibly as part of
its cytosol to mitochondria translocation (Goping et al., with the tBID molecule (i.e., cytochrome c release and
activation of caspases) require an intact BH3 domain,1998; Wood et al., 1998). Moreover, the amino terminus
of BAX appears to be normally blocking membrane in- translocation of tBID from cytosol to mitochondria can
occur with a mutated BH3 (Wang et al., 1996; Luo etsertion, and its removal enables BAX to target mitochon-
drial membranes (Goping et al., 1998). al., 1998). We suggest that the marked change in tBID
surface electrostatics and hydrophobic exposure is likely
the driving force in tBID membrane localization and sub-Change in Surface Character between BID and tBID
Caspase 8 cleavage results in marked changes in the sequent membrane insertion.
Minor BID cleavage products of p13 and p11 frag-character of BID surfaces. Changes in hydrophobic ex-
posure and surface charge likely contribute to the rapid ments are noted following TNF and FAS activation. While
p15 BID appears to be cleaved in the cytosol and trans-change in cellular distribution for the BID molecule ob-
served upon cleavage. The cleavage event results in the locates to mitochondria, the p13 and p11 BID fragments
are only observed in mitochondria as integral membraneexposure of .200 AÊ 2 of previously buried surface area
(compare Figures 5c and 5d). The composition of sur- proteins. This suggests the p13 and p11 cleavages
might be generated following integration and appear toface-exposed residues in the p22 and p15 isoforms are
considerably different. In addition to the change in sur- be mediated by caspase(s) other than Caspase 8 (Gross
et al., 1999). Of note, the p13 cleavage site at D75 alsoface hydrophobicity, the electrostatic character of the
BID molecule changes markedly upon cleavage by Cas- resides in the flexible loop and would retain the BH3
domain, whereas the p11 site at D98 would release thepase 8. The net charge of the molecule changes from
213 in the p22 molecule to 24 in the p15 product. A BH3 domain (Figure 3a). This suggests a model consis-
tent with the predicted structure of p15 BID (Figures 5striking difference can be seen in comparing the surface
Structure of the Proapoptotic Death Domain BID
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Figure 6. A Comparison of the Change in
Surface Charge between BID and the tBID
Model
The overall charge in the two molecules is
213 for BID (a) and 24 for the tBID model (b).
The surface electrostatic potential is coded
such that regions with electrostatic poten-
tial ,28 kBT are red, while those .18 kBT
are blue (kB, Boltzmann constant; T, absolute
temperature).
and 6) in which the hydrophobic core aFG would be cytosolic components but induce death upon their tar-
geting to mitochondria. The second, and perhaps moretransmembrane, while aC (BH3 domain) would remain
exposed on the surface of the mitochondria. The amino critical, criterion for death agonism is the exposure of
the BH3 surface. The cleavage of BID by Caspase 8 isterminus of BAX also becomes more susceptible to pro-
teolytic cleavage following membrane integration (Gop- likely to expose a BH3 motif that is buried in the un-
cleaved molecule. Based on our structure predictionsing et al., 1998). There still remains the question of why
Caspase 8 cleavage in a flexible loop would lead to the for the BCL2 family, some members of the ªBH3 domain
onlyº class appear to have their BH3 motif exposed ordissociation of helices aA and aB. With respect to this
question, we do note that the hydrogen-deuterium ex- at least not under the same conformational constraints
as other members of the BCL2 family. Molecules pos-change rates for aA and aB are faster than other helices
in BID (see Figure 1); this may imply some conforma- sessing an exposed BH3 motif (EGL-1, HRK, BIK, BIM,
tBID) might be expected to be constitutively active deathtional equilibrium between the aAB structural unit and
the rest of the BID protein. There may also be involve- agonists. Other members of the family possessing a
ªhiddenº BH3 motif would be activated by posttransla-ment of third parties in the dissociation of the aAB
segment. tion modification events that expose the BH3 epitope
and manifest their proapoptotic function.
Model of BID-Mediated Apoptosis
The exposure of the BH3 domain in BID and the pro- Experimental Procedures
apoptotic function of the molecule is regulated through
Expression of BIDa posttranslational cleavage event. Other mechanisms
Full-length mouse BID cDNA was cloned into the NcoI site of theof posttranslational modification regulate activities of
pGEX-KG GST fusion vector (Pharmacia). Protein sequences based
other group I subset (Figure 3) members (Cheng et al., on this vector have 15 additional N-terminal amino acids, namely
1997; Gross et al., 1998). This type of regulation allows GSPGISGGGGGILDS before the M residue in the mouse BID cDNA.
The expressed sequence was then gspgisgggggildsMDSEVSNGSGthe rapid response necessary for apoptosis. Other group
LGAKHITDLLVFGFLQSSGCTRQELEVLGRELPVQAYWEADLEDELQII constitutively active members may be regulated at the
TDGSQASRSFNQGRIEPDSESQEEIIHNIARHLAQIGDEMDHNIQPTLlevel of transcription, as predicted for EGL-1 (Conradt
VRQLAAQFMNGSLSEEDKRNCLAKALDEVKTAFPRDMENDKAMLand Horvitz, 1998) and observed for HRK (Inohara et
IMTMLLAKKVASHAPSLLRDVFHTTVNFINQNLFSYVRNLVRNEMD.
al., 1997). As predicted, the group II member BAD is For 15N and 15N, 13C samples, the following general procedure was
constitutively active in its native nonphosphorylated used. BL21DE3 cells containing this fusion protein construct were
grown in LB (with 100 mg/ml ampicillin) initially, then seeded intoform, while phosphorylation results in structural changes
minimal MOPS media (100 mg/ml ampicillin) and stored as glycerolthat inactivate the molecule and prevent its BH3 motif
stocks in minimal MOPS media. Minimal MOPS media: 40 mMfrom binding BCL2 (Zha et al., 1996).
MOPS (pH 7.4) (KOH), 4 mM Tricine (pH 7.4) (KOH), 0.01 mM FeSO4,The structure of BID sheds light on its role as a death
0.276 mM K2SO4, 0.5 mM CaCl2, 0.528 mM MgCl2, 50 mM NaCl,agonist and the requirements for proapoptotic action in 0.72 mM Na2MoO4, 4 mM H3BO4, 0.55 mM CoCl2, 0.108 mM CuSO4,
the BCL2 family. What makes a BCL2 family member a 1.26 mM MnCl2, 0.178 mM ZnSO4, 13 vitamin solution (5003: in
10 ml dissolve, 16.8 mg thiamine, 11.9 mg pantothenic acid, 8 mgdeath agonist? It appears that two criteria must be met
p-hydroxybenzoic acid, 6.9 mg p-aminobenzoic acid, 7.7 mg 2,3-for proapoptotic function. The first requirement is one of
dihydroxybenzoic acid), 13.1 mM K2HPO4, 2 g [U-13C]Glucose, 1 gcellular localization. There is strong evidence for several
15NH4Cl. A 200 ml culture was grown in minimal MOPS media supple-BCL2 family members that mitochondrial translocation
mented with [U-13C]Glucose overnight at 378C. Ten milliliters of this
is a key determinant for death inducing activity. BID (Li overnight culture was inoculated into 1 l of minimal MOPS media
et al., 1998; Luo et al., 1998; Gross et al., 1999) and BAX (100 mg/ml ampicillin) and grown until OD600 was 0.7. [U-13C]Glucose
was added and induction was with 1 mM IPTG for 4 hr.(Wolter et al., 1997; Gross et al., 1998) are inactive as
Cell
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Cleavage and Purification from GST high-frequency components (PHF) of local motion (Fushman and
Cowburn, 1998) as follows (Farrow et al., 1995): R195 R1 2 6.25PHF;Pelleted bacteria were resuspended in 14 ml (per 1 l of culture) of
lysis solution (1% Triton X-100, 1 mM EDTA, PBS, and protease R295 R2 2 5.39PHF, where PHF 5 (gN/gH)(1 2 NOE)R1/5 and gN and gH
are gyromagnetic ratios for 15N and 1H. For the derivation of theinhibitors [Pepstatin A, Aprotinin, Leupeptin, PMSF]). Lysis was by
sonication, and debris was pelleted at 9000 rpm. The GST-BID fusion relative orientation of individual helices with respect to the overall
diffusion tensor, the average orientation of each backbone amideprotein was captured from supernatant with GSH-agarose beads in
lysis solution at 48C with mixing for 1 hr. Beads were washed four was calculated based on the NMR-derived bundle of 20 structures.
The orientation of the principal axes of the rotational diffusion tensortimes with lysis solution and then three times with 0.1% Triton X-100
lysis solution, followed with washing four times with sterile PBS. was derived using the R2/R1 ratios (Copie et al., 1998). The analysis,
applied to 20 generated BID structures with the lowest target func-GST was cleaved from the fusion protein with human thrombin (600
units thrombin [Caltag] in 150 mM NaCl, 2.5 mM CaCl2, 5 mM DTT) tion, yielded the following averaged characteristics of the overall
rotation: tc 5 9.44 6 0.03 ns, D‖/D⊥ 5 1.18 6 0.01, Q 5 658 6 68,for 2 hr at room temperature. The digestion was stopped with 5 mM
EDTA and protease inhibitors. Beads were pelleted, supernatants and φ 5 278 6 88. The values for individual amide orientations
were averaged for each helical segment, giving an average relativewere pooled, and beads were washed four times with PBS, 0.1%
Triton X-100, 1 mM EDTA, and protease inhibitors. BID was concen- orientation for each helix.
trated with an Amicon concentrator. BID was purified over a Phar-
macia MonoQ anion affinity column and eluted with an increasing Structure Prediction for Family Members
NaCl gradient. Mass spectra of products were correct for the se- For the sequence alignment for the BCL2 family, the program CLUS-
quence used. NMR samples were dialyzed and concentrated into TALW (Thompson et al., 1994) was used initially. However, the low
50 mM NaCl, 50 mM sodium phosphate (pH 6.0), 2 mM deuterated level of similarity often necessitated aligning sequences by hand.
DTT, 2 mM deuterated EDTA, 0.02% sodium azide, plus 10% D20. GenBank accession numbers are as follows: BID, g1669514; BCL-
Final concentrations ranged from 400 mM to 1.4 mM; spectra were XL, g728955; BCL2, g231632; CED-9, g1168881; BCL-W, g2493278;
independent of concentration in this range. BAX, g728945; BAK, g2493274; BAD, g2493287; EGL-1, g3133315;
BIK, g1235989. The aligned sequences were then subjected to sec-
ondary structure prediction methods. A number of programs wereNMR Spectroscopy
used for this analysis. Where possible, the results displayed in FigureThe assignment and structure derivation of BID were determined
3b represent a consensus of the multiple approaches used. Theusing standard heteronuclear NMR methods, as in McDonnell et al.
following programs contributed to BCL2 family secondary structure(1998). Assignment made use of the following NMR experiments:
predictions: PSA (Stultz et al., 1993), PHDsec (Rost et al., 1994),HNCA, HN(CO)CA, CBCANH, CBCA(CO)NH, HNCO, HN(CA)CO,
PREDATOR (Frishman and Argos, 1996), DSC (King and Sternberg,HNHA, and HCCH-TOCSY (Clore et al., 1990; Grzesiek et al., 1992;
1996), SOPMA (Geourjon and Deleage, 1995), and BCM PSSPGrzesiek and Bax, 1993; Bagby et al., 1994). The high degree of
(Solovyev and Salamov, 1994).redundancy in this approach allowed us to overcome significant
spectral overlap to make unambiguous assignments. Automated
structure calculations were performed using the program DYANA Acknowledgments
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